16p11.2p12.2 microduplication syndrome

16p11.2p12.2 microduplication syndrome (Orphanet code 261204) is a rare chromosomal anomaly caused by a duplication of genetic material on the short arm of chromosome 16, spanning the region from band p11.2 to p12.2. This genomic imbalance is larger than the more commonly described proximal 16p11.2 microduplication and encompasses additional genes, which may contribute to a broader and more variable clinical presentation. The syndrome primarily affects neurodevelopment and can involve multiple body systems. Key clinical features include intellectual disability of variable severity, developmental delay (particularly speech and language delay), and behavioral abnormalities that may include features of autism spectrum disorder. Affected individuals may also present with dysmorphic facial features, feeding difficulties in infancy, hypotonia (low muscle tone), and growth abnormalities. Some patients have been reported with congenital anomalies affecting the heart, skeletal system, or other organs, though the phenotype is highly variable even among individuals carrying similar duplications. There is no specific cure or targeted therapy for 16p11.2p12.2 microduplication syndrome. Management is supportive and symptom-based, typically involving early intervention programs, speech and language therapy, occupational therapy, behavioral support, and special educational services. Regular developmental monitoring and screening for associated medical complications, such as cardiac defects, are recommended. Genetic counseling is important for affected families, as the duplication may be inherited from a mildly affected or apparently unaffected parent, or may arise de novo.

Common questions about 16p11.2p12.2 microduplication syndrome